NCT00501150View on ClinicalTrials.gov

Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections

NACompletedINTERVENTIONAL
Enrollment

211

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Gram-positive Bacterial InfectionsStaphylococcal Infections
Interventions
DRUG

linezolid

Linezolid is an antimicrobial with activity against MRSA that can be given orally.

Trial Locations (1)

w12 0nn

Imperial College London, London

All Listed Sponsors
collaborator

Hammersmith Hospitals NHS Trust

OTHER

lead

Imperial College London

OTHER

NCT00501150 - Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections | Biotech Hunter | Biotech Hunter